Gene · 4818
Papers1,677
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,677
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell landscape of the cellular microenvironment in three different colonic polyp subtypes in children. | Clin Transl Med | 2024 | 38264936 | PubTator, text mining | PubMed |
| Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication. | Int J Mol Sci | 2024 | 38256278 | PubTator, text mining | PubMed |
| Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response. | Metabolites | 2024 | 38248854 | PubTator, text mining | PubMed |
| Helios characterized circulating follicular helper T cells with enhanced functional phenotypes and was increased in patients with systemic lupus erythematosus. | Clin Exp Med | 2024 | 38240853 | PubTator, text mining | PubMed |
| Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction. | Clin Transl Med | 2024 | 38239097 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq Elucidates the Crosstalk Between Cancer Stem Cells and the Tumor Microenvironment in Hepatocellular Carcinoma. | J Cancer | 2024 | 38230205 | PubTator, text mining | PubMed |
| Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma. | Heliyon | 2024 | 38223729 | PubTator, text mining | PubMed |
| T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis. | iScience | 2024 | 38222108 | PubTator, text mining | PubMed |
| Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer. | J Immunother Cancer | 2024 | 38199610 | PubTator, text mining | PubMed |
| GZMK+CD8+ T cells Target A Specific Acinar Cell Type in Sjögren's Disease. | Res Sq | 2024 | 38196575 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analyses of tumor microenvironment and molecular reprograming landscape of metastatic laryngeal squamous cell carcinoma. | Commun Biol | 2024 | 38191598 | PubTator, text mining | PubMed |
| Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease. | J Exp Clin Cancer Res | 2024 | 38191418 | PubTator, text mining | PubMed |
| Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning. | Commun Biol | 2024 | 38182876 | PubTator, text mining | PubMed |
| Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma. | Cell Death Dis | 2024 | 38182561 | PubTator, text mining | PubMed |
| The chemokine receptor CXCR3 promotes CD8+ T cell-dependent lung pathology during influenza pathogenesis. | Sci Adv | 2024 | 38170765 | PubTator, text mining | PubMed |
| M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes. | Sci Rep | 2024 | 38168909 | PubTator, text mining | PubMed |
| BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination. | Nat Commun | 2024 | 38167829 | PubTator, text mining | PubMed |
| NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer. | J Exp Clin Cancer Res | 2024 | 38167224 | PubTator, text mining | PubMed |
| Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients. | Leukemia | 2024 | 38049509 | PubTator, text mining | PubMed |
| Automated single-cell omics end-to-end framework with data-driven batch inference. | bioRxiv | 2024 | 37961197 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4818/papers?page=10